Materion Corporation filings document the regulatory disclosures of an Ohio-incorporated advanced materials company with common stock listed on the New York Stock Exchange under MTRN. Its 8-K reports include quarterly and annual operating results, earnings releases, guidance-related business updates, dividend-related corporate actions, and material operational matters tied to product quality, capacity, and customer programs.
Materion proxy and governance filings cover annual meeting votes, director elections, auditor ratification, executive compensation, board committee matters, equity incentive awards, and shareholder voting results. The filings also identify the company's capital structure, registered common stock, governance practices, and disclosure controls around its advanced materials operations.
Materion Corp (MTRN) director reported routine equity awards on a Form 4. On December 5, 2025, the director acquired 17.656 shares of common stock at $0, held indirectly in a directors deferred compensation plan, bringing that indirect holding to 15,997.835 shares. The filing also shows an award of 2 restricted stock units (RSUs) acquired through dividend equivalent reinvestment, with 2,004 RSUs owned directly after the transaction. These dividend-equivalent RSUs will vest at the same time as the underlying RSUs, which is the earlier of May 8, 2026 and the date of the next annual meeting of Materion’s shareholders.
MATERION Corp (MTRN) director reported a routine equity award update. On 12/05/2025, the reporting person acquired 2 restricted stock units (RSUs) of MATERION common stock at a price of $0, reflecting dividend equivalent reinvestment. After this transaction, the reporting person beneficially owned 2,004 derivative securities in the form of RSUs held directly.
Each RSU represents the right to receive one share of MATERION common stock. These 2 additional RSUs will vest at the same time as the related RSUs, on the earlier of May 8, 2026 or the date of the next annual meeting of MATERION shareholders. The filing was executed by an attorney-in-fact under a power of attorney.
Materion (MTRN) executive VP General Counsel & Secretary reported multiple transactions on 11/04/2025. The insider exercised stock appreciation rights, acquiring 1,459 shares at $68.82 and 2,254 shares at $80.85. Shares were withheld for taxes, disposing of 1,053 at $112.96 and 1,796 at $113.13, and an open-market sale of 864 shares at $113.226 occurred the same day. Following these transactions, the insider directly owned 10,376 shares and indirectly held 5,337.344 shares in a 401(k) plan.
Materion (MTRN) received a Form 144 notice for a proposed sale of common stock by an affiliated seller. The filing lists 864 shares to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $97,827.44, on or about 11/04/2025 on the NYSE.
The shares were acquired on 11/04/2025 via Stock Appreciation Rights as compensation. As context, shares outstanding were 20,732,741. The filing also notes a prior sale during the past three months: 3,000 shares of common stock sold on 08/04/2025 for $315,511.65 by Gregory R. Chemnitz.
Materion (MTRN) reported Q3 results with net sales of 444,808 (thousands), up from 436,715. Gross margin rose to 86,123, and operating profit reached 34,943. Net income was $25,412, translating to diluted EPS of $1.22 compared with $1.07 a year ago. The quarter’s effective tax rate was 9.6%.
By segment, Electronic Materials delivered $246,837 in sales, Performance Materials $170,787, and Precision Optics $27,184. Year to date, net cash provided by operating activities was $83,724 versus $11,564 in the prior-year period. The company completed a $19.5 million cash acquisition of tantalum manufacturing assets in South Korea on July 9, 2025, allocated mainly to goodwill of approximately $14.9 million and a developed technology intangible of $2.1 million. Shares outstanding were 20,732,741 as of September 26, 2025.
Materion Corporation filed a current report to note it issued a press release announcing results for the third quarter of 2025. The announcement was made on October 29, 2025, and the press release is attached as Exhibit 99.1.
The filing falls under Item 2.02, Results of Operations and Financial Condition. Common stock of Materion trades on the NYSE under the symbol MTRN.
Director purchase reported: Patrick M. Prevost, a director of Materion Corp (MTRN), acquired 165 shares of the company's common stock on 10/06/2025 at a price of $124.42 per share. After this transaction, his reported beneficial ownership is 15,980.179 shares, held indirectly in the Directors Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 10/07/2025.
Insider transaction by Director Craig S. Shular at Materion Corp (MTRN). On 10/06/2025 the reporting person acquired 195 shares of common stock at a price of $124.42 per share and disposed of 5,908.972 shares. After the transactions, the reporting person beneficially owned 52,328.979 shares indirectly, held in a directors' deferred compensation plan. The form was signed by an attorney-in-fact on 10/07/2025.
Emily M. Liggett, a director of Materion Corporation (MTRN), reported transactions on 09/05/2025. The filing discloses the acquisition of 2 restricted stock units that each represent a right to one share and were recorded at a price of $0; those units will vest in line with the related restricted stock units (vesting no later than May 8, 2026 or the next annual meeting). The report also shows 2,002 shares beneficially owned following the reported derivative transactions (direct) and 1,267.944 shares held indirectly in the Directors Deferred Compensation Plan. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Gregory R. Chemnitz, Vice President, General Counsel & Secretary of Materion Corporation (MTRN), reported a small grant of 5 restricted stock units (RSUs) on 09/05/2025 that were acquired upon reinvestment of dividend equivalents. Each RSU represents a right to one share of common stock and will vest at the same time as the related RSUs. Following the transaction, he beneficially owns 3,961 shares directly. The reported RSUs carry a $0 purchase price. The Form 4 was signed by an attorney-in-fact, Michelle R. Mekinda, on 09/09/2025.